ADSCP2 RNA-seq all.counts.group2_vs_group1.edgeR_all.xls

hypertrophic scar fibroblasts were subjected to treatment with either 25 μM Sc (Control) or ADSCP2 in triplicate, followed by collection for the preparation of a transcriptome library and sequencing (Illumina NovaSeq6000, in PE150 mode), a process carried out by the ShanghaiBio Corporation.将增生性瘢痕成纤维细胞（hypertrophic scar fibroblasts）分为两组，一组经25 μM的Sc（对照组）处理，另一组经ADSCP2处理，每组均设置三次生物学重复；随后收集各组样本以制备转录组文库（transcriptome library），并采用Illumina NovaSeq6000平台、PE150测序模式完成测序，该实验流程由上海生物科技有限公司（ShanghaiBio Corporation）执行。